Dupuytren's ContractureGRASP-DCNCT05877066
Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
An observational study of Dupuytren's Contracture, run by Endo USA Inc., a Keenova Therapeutics Company at 7 sites in United States.
Trial summary
This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dupuytren's Contracture
- How many people
- 130 participants
- Where
- 7 sitesUnited States
- Study dates
- 14 Jun 2023to 26 Feb 2024
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Participants with a confirmed diagnosis of DC will be enrolled in the United States.
Who may be able to join
- Any adult with a confirmed clinical diagnosis of DC.
- Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment.
- Willing to participate in the registry (including completion of ePROs) and complete the informed consent form.
- Having received DC treatment, either non-surgical or surgical, within 2 weeks before enrollment, at enrollment or any time after the date of enrollment or not having received DC treatment after confirmed diagnosis of DC.
- Able to participate in English based registry.
Who cannot join
- Not having a clinical diagnosis of DC.
- Age less than 18 years.
- Do not provide informed consent.
Trial locations and contacts
7 sites in 1 country.
7 sites in 1 country
United States7 sites
Endo Pharmaceuticals Clinical Site 3
Bend, Oregon, 97701
Endo Pharmaceuticals Clinical Site 7
Charlotte, North Carolina, 28207
Endo Pharmaceuticals Clinical Site 1
Eatontown, New Jersey, 07774
Endo Pharmaceuticals Clinical Site 5
Greenwich, Connecticut, 06831
Endo Pharmaceuticals Clinical Site 2
Indianapolis, Indiana, 46260
Endo Pharmaceuticals Clinical Site 6
Phoenix, Arizona, 85015
Endo Pharmaceuticals Clinical Site 4
Temple Terrace, Florida, 33637
About this study
Official title: Generating Real-world Ambispective Data to Study Participant Treatment Outcomes for Dupuytren's Contracture
This is an observational study, meaning participants will not receive any investigational treatment as part of this study.
Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.
Read the detailed description
Each participant of the study will have their data collected from the date of confirmed diagnosis of DC to the date of enrollment in the registry, post consent. Data will be collected from the participants clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.
- Conditions
- Dupuytren's Contracture
- Keywords
- Real world data, Retrospective, Prospective, Registry
- Medical subject headings
- Dupuytren Contracture
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants Receiving Each Treatment Type for DC
Measured: Up to 36 months
Secondary outcomes (5)
Change from Baseline in Michigan Hand Questionnaire (MHQ) Scale Score
Measured: Up to 36 months
Change from Baseline in European Quality of Life Five Dimension (EQ-5D) Questionnaire Score
Measured: Up to 36 months
Change from Baseline in Unité Rhumatologique des Affections de la Main (URAM) Scale Score
Measured: Up to 36 months
Participant Satisfaction Questionnaire
Measured: Up to 36 months
Number of Participants Receiving Post-Procedural Care by the Treating Physician
Measured: Up to 36 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2023
- Study start14 Jun 2023
- Primary completion26 Feb 2024
- Study completion26 Feb 2024
Why it stopped: Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dupuytren's ContractureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 130 participants (actual)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Pulse Infoframe
- Responsible party
- Sponsor
- Investigators
- Medical Information, Study director, Endo USA Inc., a Keenova Therapeutics Company
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05877066
- Sponsor's protocol ID
- EP01REG
- Acronym
- GRASP-DC
- Status last verified
- Apr 2024
- First submitted
- 17 May 2023
- Last updated
- 16 Apr 2024
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Generating Real-world Ambispective Data to Study Participant Treatment Outcomes for Dupuytren's Contracture
- ClinicalTrials.gov ID
- NCT05877066
- Acronym / sponsor ID
- GRASP-DC / EP01REG
- Conditions
- Dupuytren's Contracture
- Keywords
- Real world data, Retrospective, Prospective, Registry
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.
- Enrolment
- 130 participants (actual)
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics CompanyIndustry (pharma, biotech, devices)
- Collaborators
- Pulse Infoframe
- Study start
- 14 Jun 2023 (actual)
- Primary completion
- 26 Feb 2024 (actual)
- Study completion
- 26 Feb 2024 (actual)
- First posted
- 26 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is an observational study, meaning participants will not receive any investigational treatment as part of this study.
Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.
Detailed description
Each participant of the study will have their data collected from the date of confirmed diagnosis of DC to the date of enrollment in the registry, post consent. Data will be collected from the participants clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Target follow-up
- 3 Years
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Participants with a confirmed diagnosis of DC will be enrolled in the United States.
Key inclusion criteria (5 listed)
- Any adult with a confirmed clinical diagnosis of DC.
- Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment.
- Willing to participate in the registry (including completion of ePROs) and complete the informed consent form.
- Having received DC treatment, either non-surgical or surgical, within 2 weeks before enrollment, at enrollment or any time after the date of enrollment or not having received DC treatment after confirmed diagnosis of DC.
- Able to participate in English based registry.
Key exclusion criteria (3 listed)
- Not having a clinical diagnosis of DC.
- Age less than 18 years.
- Do not provide informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of Participants Receiving Each Treatment Type for DC
Time frame: Up to 36 months
5 secondary outcomes
Change from Baseline in Michigan Hand Questionnaire (MHQ) Scale Score
Time frame: Up to 36 months
Change from Baseline in European Quality of Life Five Dimension (EQ-5D) Questionnaire Score
Time frame: Up to 36 months
Change from Baseline in Unité Rhumatologique des Affections de la Main (URAM) Scale Score
Time frame: Up to 36 months
Participant Satisfaction Questionnaire
Time frame: Up to 36 months
Number of Participants Receiving Post-Procedural Care by the Treating Physician
Time frame: Up to 36 months
Results and safety
The study was stopped early (reason given: Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2024.
Related trials for Dupuytren's Contracture
Not yet recruiting
Kinesitherapy Plus Osteopathy After Surgery for Dupuytren Disease
Dupuytren Disease
Not yet recruitingPhase 3
DEPART Study at Yale
Dupuytren's Contracture
Not yet recruiting
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
Non-traumatic Musculoskeletal Conditions, Carpal Tunnel Syndrome (CTS)
Recruiting
Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
Dupuytren Contracture
Not yet recruitingPhase 2
NAC-REPAIR for Post-surgical Pain
Carpal Tunnel Surgery, Trigger Finger Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Medical Information study director
Endo USA Inc., a Keenova Therapeutics Company
7 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dupuytren's Contracture, run by Endo USA Inc., a Keenova Therapeutics Company at 7 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 16 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 7 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Participants Receiving Each Treatment Type for DC (time frame: Up to 36 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2024.